Personality and side effects of glaucoma eye drops
Part of Eyes & vision clinical trials.
This study looks at whether your personality affects how you experience side effects from glaucoma eye drops. The results may help doctors choose the best treatment for you and provide more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with glaucoma.
- You are currently using, or have used in the past, a glaucoma medication (eye drops or other).
- You can give your informed consent to take part.
- You can complete questionnaires in English or French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how glaucoma affects your body's natural light sensing, which can impact sleep, alertness, mood, and memory. Researchers compare people with glaucoma to healthy volunteers to understand these effects better.
This study examines how glaucoma affects day-to-day life. It asks people with any type of glaucoma to complete a questionnaire about their quality of life.
This study looks at whether a common class of glaucoma eye drops (called prostaglandin analogues) can protect the nerve cells in the back of the eye. It may help people with certain types of glaucoma who have been stable on one type of eye drop for at least 3 years.
This study tests whether an online meditation program can help reduce stress in people with glaucoma who are 65 or older. Participants will learn meditation techniques during virtual sessions and practice at home.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
This study looks at tools to help people use their glaucoma eyedrops correctly. You may be eligible if you've been on the same drops for 2 months and are a patient at Boston University Eye Associates.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.